Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Implementation of Primary Human Papillomavirus (HPV) Testing in the Organized Screening for Cervical Cancer in Stockholm

NCT01511328 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT01511328
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01511328 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Implementation of Primary Human Papillomavirus (HPV) Testing in the Organized Screening for Cervical Cancer in Stockholm
Lead sponsor
Karolinska Institutet
Phase
Not applicable
Overall status
Active, not recruiting
Start date
January 1, 2012
Completion date
December 31, 2031
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

high-grade cervical intraepithelial neoplasia, invasive cervical cancer